DalsnaFinance › IPOs › Trevi Therapeutics Inc › IPO
Trevi Therapeutics, Inc. completed its initial public offering on NASDAQ on May 7, 2019, pricing at $10.00 a share.
| Ticker | TRVI |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 7, 2019 |
| Offering price | $10.00 |
| Shares offered | 5,500,000 |
| Total raised | $55M |
Trevi Therapeutics, Inc. sold 5,500,000 shares at $10.00 each on NASDAQ. Multiplied out, that is $55 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $55 million total recorded for the deal.
Trevi Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Trevi Therapeutics, Inc.. This page is general information, not investment advice.